Rekvina Laboratories Limited (BOM:526075)
25.30
0.00 (0.00%)
At close: Jul 24, 2026
Rekvina Laboratories Revenue
In the fiscal year ending March 31, 2026, Rekvina Laboratories had annual revenue of 12.65M INR. Rekvina Laboratories had revenue of 7.24M in the quarter ending March 31, 2026.
Revenue
12.65M
Revenue Growth
n/a
P/S Ratio
12.05
Revenue / Employee
2.53M
Employees
5
Market Cap
152.51M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 12.65M | - | - |
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Add-Shop E-Retail | 1.55B |
| Beryl Drugs | 188.20M |
| Unjha Formulations | 155.85M |
| Zenith Healthcare | 105.22M |
| Hamps Bio | 84.75M |
| Norris Medicines | 81.32M |
| Desh Rakshak Aushdhalaya | 71.04M |
| Colinz Laboratories | 61.36M |